Please wait a minute...
文章检索
预防医学  2026, Vol. 38 Issue (7): 657-660,665    DOI: 10.19485/j.cnki.issn2096-5087.2026.07.003
  论著 本期目录 | 过刊浏览 | 高级检索 |
2016—2024年金华市甲状腺癌发病变化趋势分析
王诚, 王小红, 周凡
金华市疾病预防控制中心,浙江 金华 321000
Trend in incidence of thyroid cancer in Jinhua City from 2016 to 2024
WANG Cheng, WANG Xiaohong, ZHOU Fan
Jinhua Center for Disease Control and Prevention, Jinhua, Zhejiang 321000, China
全文: PDF(859 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 了解2016—2024年浙江省金华市甲状腺癌发病率变化趋势,为优化甲状腺癌防控策略提供依据。方法 通过浙江省慢性病监测信息管理系统收集2016—2024年金华市甲状腺癌发病资料,计算粗发病率,采用2010年第六次全国人口普查数据计算标化发病率。采用平均年度变化百分比(AAPC)分析2016—2024年甲状腺癌发病率变化趋势;采用线性回归模型计算平均发病年龄,分析2016—2024年甲状腺癌平均发病年龄变化趋势。结果 2016—2024年金华市全人群甲状腺癌粗发病率、标化发病率分别为59.76/10万、56.18/10万,呈上升趋势(AAPC=11.447%、12.457%,均P<0.05);男性分别为29.55/10万、28.94/10万,呈上升趋势(AAPC=14.237%、14.568%,均P<0.05);女性分别为90.71/10万、84.76/10万,呈上升趋势(AAPC=11.017%、11.696%,均P<0.05)。全人群、男性和女性甲状腺癌粗发病率随年龄增长先上升后下降,分别在40~<45岁、40~<45岁和45~<50岁组达峰值,为112.56/10万、57.51/10万和172.29/10万。2016—2024年15~<80岁各年龄组甲状腺癌粗发病率呈上升趋势(均P<0.05),≥80岁组变化趋势无统计学意义(P>0.05)。全人群甲状腺癌平均发病年龄为47.36岁,其中男性平均发病年龄为46.57岁,低于女性的47.62岁(P<0.05)。男性甲状腺癌平均发病年龄从2016年的45.80岁增长至2024年的47.16岁,年均增加0.23岁(P<0.05);全人群、女性平均发病年龄变化趋势无统计学意义(均P>0.05)。结论 2016—2024年金华市甲状腺癌发病率呈上升趋势,需加强女性、中年人群甲状腺癌早期筛查与干预。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
王诚
王小红
周凡
关键词 甲状腺癌发病率发病年龄平均年度变化百分比    
AbstractObjective To investigate the trend in incidence of thyroid cancer in Jinhua City, Zhejiang Province from 2016 to 2024, so as to provide a basis for optimizing prevention and control strategies for thyroid cancer. Methods Data on incidence of thyroid cancer in Jinhua City from 2016 to 2024 were collected through the Zhejiang Provincial Chronic Disease Surveillance Information Management System. The crude incidence of thyroid cancer was calculated and standardized using the data from the Sixth National Population Census in 2010. The average annual percent change (AAPC) was used to analyze the temporal trend in incidence of thyroid cancer from 2016 to 2024, and a linear regression model was employed to calculate average age of onset and analyze its trend over the same period. Results From 2016 to 2024, the crude incidence and age-standardized incidence of thyroid cancer in Jinhua City were 59.76/105 and 56.18/105, respectively, showing increasing trends (AAPC=11.447%, 12.457%, both P<0.05). The crude incidence and age-standardized incidence for males were 29.55/105 and 28.94/105, respectively, also showing increasing trends (AAPC=14.237%, 14.568%, both P<0.05). For females, the crude incidence and age-standardized incidence were 90.71/105 and 84.76/105, with significant increasing trends (AAPC=11.017%, 11.696%, both P<0.05). The crude incidence of thyroid cancer for the overall population, males, and females first increased and then decreased with advancing age, peaking at ages 40-<45 years, 40-<45 years, and 45-<50 years, with peak rates of 112.56/105, 57.51/105 and 172.29/105, respectively. From 2016 to 2024, the crude incidence of thyroid cancer showed increasing trends across all age groups from 15-<80 years (all P<0.05), whereas no statistically significant trend was observed in the ≥80 years age group (P>0.05). The average age of onset of thyroid cancer in the overall population was 47.36 years. The average age of onset for males, which was significantly lower than that for females (46.57 vs. 47.62 years, P<0.05). The average age of onset for males increased from 45.80 years in 2016 to 47.16 years in 2024, with an average annual increase of 0.23 years (P<0.05). No statistically significant trend in the average age of onset was observed for the overall population or for females (both P>0.05). Conclusion The incidence of thyroid cancer in Jinhua City showed an increasing trend from 2016 to 2024, highlighting the need to strengthen early screening and intervention for thyroid cancer among women and middle-aged populations.
Key wordsthyroid cancer    incidence    age at onset    average annual percent change
收稿日期: 2026-04-01      修回日期: 2026-07-06      出版日期: 2026-07-10
中图分类号:  R736.1  
基金资助:金华市科技局基金资助项目(2024-4-173)
作者简介: 王诚,硕士,主管医师,主要从事慢性病监测与防制工作,E-mail:928714021@qq.com
引用本文:   
王诚, 王小红, 周凡. 2016—2024年金华市甲状腺癌发病变化趋势分析[J]. 预防医学, 2026, 38(7): 657-660,665.
WANG Cheng, WANG Xiaohong, ZHOU Fan. Trend in incidence of thyroid cancer in Jinhua City from 2016 to 2024. Preventive Medicine, 2026, 38(7): 657-660,665.
链接本文:  
https://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2026.07.003      或      https://www.zjyfyxzz.com/CN/Y2026/V38/I7/657
[1] Zhang L,Jiang L L,Xu R,et al.Epidemiological study of thyroid cancer at global,regional,and national levels from 1990 to 2021:an analysis derived from the Global Burden of Disease Study 2021[J/OL].Front Endocrinol,2025,16[2026-07-06].https://doi.org/10.3389/fendo.2025.1644270.
[2] Zhai M M,Zhang D,Long J H,et al.The global burden of thyroid cancer and its attributable risk factor in 195 countries and territories:a systematic analysis for the Global Burden of Disease Study[J].Cancer Med,2021,10(13):4542-4554.
[3] Bray F,Ferlay J,Soerjomataram I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[4] Bray F,Laversanne M,Sung H,et al.Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countrie[J].CA Cancer J Clin,2024,74(3):229-263.
[5] 赫捷,魏文强.2021中国肿瘤登记年报[M].北京:人民卫生出版社,2023.
[6] 王裕新,潘凯枫,李文庆.2022全球癌症统计报告解读[J].肿瘤综合治疗电子杂志,2024,10(3):1-16.
[7] Lyu Z Y,Zhang Y,Sheng C,et al.Global burden of thyroid cancer in 2022:incidence and mortality estimates from GLOBOCAN[J].Chin Med J,2024,137(21):2567-2576.
[8] 项彩英,陈颖,汪德兵,等.2021年浙江省肿瘤登记地区甲状腺癌发病与死亡特征及2000—2021年变化趋势分析[J].中国肿瘤,2025,34(10):756-763.
[9] 王小红,周凡,陈梦倩,等.2016—2024年金华市恶性肿瘤发病特征及流行趋势预测[J].中国慢性病预防与控制,2026,34(5):398-401.
[10] 郭晓慧,王丽敏,王辉,等.2007—2016年天津市南开区甲状腺癌发病和死亡趋势分析[J].中国慢性病预防与控制,2021,29(11):878-881.
[11] 闫瑞平,李建彬,安戈,等.2016—2021年郑州市肿瘤登记地区甲状腺癌发病和死亡趋势分析[J].预防医学,2026,38(3):267-273.
[12] 苏幸,郑琳,章华米,等.2010—2020年浙江省杭州市西湖区甲状腺癌发病特征和流行趋势分析[J].疾病监测,2022,37(10):1367-1370.
[13] 韩亚蓉,韩颖颖,蔡波,等.2013—2022年南通市甲状腺癌发病和死亡趋势分析[J].预防医学,2026,38(1):20-25.
[14] 胡珊,庄一渝,朱炜琴,等.健康体检人群甲状腺结节检出情况及相关因素分析[J].中华保健医学杂志,2023,25(2):196-199.
[15] Lin Y T,Wu Y.Trends in incidence and overdiagnosis of thyroid cancer in China,Japan,and South Korea[J].Cancer Sci,2023,114(10):4052-4062.
[16] Han M A,Kim J H.Diagnostic X-ray exposure and thyroid cancer risk:systematic review and meta-analysis[J].Thyroid,2018,28(2):220-228.
[17] 渠宁,王钰婷,马奔,等.2022年度甲状腺癌研究及诊疗新进展[J].中国癌症杂志,2023,33(5):423-430.
[18] 李永浩,高雪菲,郭田田,等.肥胖合并甲状腺癌相关机制的研究进展[J/OL].中华普通外科学文献(电子版),2023,17(4):311-315.
[19] 胡君,周锋,姜涌斌,等.中青年甲状腺结节患者发生甲状腺癌的工作、生活行为方式影响因素[J].环境与职业医学,2024,41(2):200-206.
[20] 张亦涵,徐浣白.雌激素及其信号通路与甲状腺乳头状癌关系的研究进展[J].国际内分泌代谢杂志,2023,43(3):225-228.
[21] Fernandes-Taylor S,Bowles E J A,Venkatesh M,et al.Differential ultrasound rates mirror sex disparities in thyroid cancer[J].Thyroid,2024,34(12):1531-1539.
[22] Papaleontiou M,Norton E C,Reyes-Gastelum D,et al.Competing causes of death in older adults with thyroid cancer[J].Thyroid,2021,31(9):1359-1365.
[23] 滕勇勇,谢水仙,陈美婷,等.2010—2017年广东省珠海市甲状腺癌发病特征与趋势分析[J].河南预防医学杂志,2021,32(8):578-582.
[24] 董雯婷,王占明,宇应涛.3 750例甲状腺癌住院病例特征分析[J].中国病案,2023,24(6):73-75.
[1] 李卫丹, 唐慧玲, 金屡华, 朱凯强, 陈依娜. 2015—2024年金华市淋病流行特征分析[J]. 预防医学, 2026, 38(7): 722-725.
[2] 任露露, 闵艺璇, 顾嘉昌, 张思晨, 乔健健, 胡静. 2013—2022年宜兴市肺癌发病和死亡变化趋势分析[J]. 预防医学, 2026, 38(7): 675-679,685.
[3] 朱跃蒙, 倪朝荣, 谢华森, 李晓伟, 余向华, 黄洁茹. 2015—2025年温州市其他感染性腹泻流行特征分析[J]. 预防医学, 2026, 38(7): 703-705,710.
[4] 胡蔡松, 余向华, 魏晶娇, 高豪俊, 李万仓, 王冰倩, 叶振淼. 2012—2024年温州市水痘流行特征分析[J]. 预防医学, 2026, 38(7): 711-713.
[5] 曹乙, 丁炀, 邓方缘, 刘晶晶. 2015—2025年安吉县5种主要消化系统恶性肿瘤死亡及寿命损失分析[J]. 预防医学, 2026, 38(7): 726-730.
[6] 姜雪霞, 叶振淼, 樊丽辉, 郑宇航, 罗永园, 李慧君, 夏喆铮. 2015—2022年温州市女性乳腺癌发病趋势分析[J]. 预防医学, 2026, 38(5): 478-482.
[7] 李景琦, 李晨曦, 董立平. 1994—2023年中国脑卒中发病和死亡的年龄-时期-队列分析[J]. 预防医学, 2026, 38(5): 488-492,497.
[8] 徐露婷, 田雨涵, 蒲焱. 贵阳市恶性肿瘤疾病负担分析[J]. 预防医学, 2026, 38(5): 517-522.
[9] 冯豪, 李广辉, 田阳阳, 葛锐. 2015—2024年嘉兴市生殖道沙眼衣原体感染流行特征及趋势分析[J]. 预防医学, 2026, 38(5): 493-497.
[10] 曹元, 沈钲杰, 谢开婿. 2015—2024年桐乡市结直肠癌发病和死亡趋势分析[J]. 预防医学, 2026, 38(5): 536-540.
[11] 韦艳炼, 农圣, 漆光紫, 江建明. 1990—2023年中国肝癌疾病负担变化趋势及年龄-时期-队列分析[J]. 预防医学, 2026, 38(5): 473-477.
[12] 杨慧, 张以祥, 赵梅玲. 2006—2024年洪泽区HIV/AIDS病例特征分析[J]. 预防医学, 2026, 38(4): 402-405.
[13] 金茜, 叶振淼, 姜雪霞, 樊丽辉, 张默涵, 谢轶敏, 罗永园, 郑宇航. 2016—2023年温州市糖尿病发病趋势分析[J]. 预防医学, 2026, 38(4): 372-376.
[14] 李海华, 叶勇, 袁瑞, 运靖宜, 王浩博, 傅雨欣. 2006—2025年湖州市儿童青少年糖尿病发病趋势及年龄-时期-队列分析[J]. 预防医学, 2026, 38(3): 257-262.
[15] 闫瑞平, 李建彬, 安戈, 郭向娇, 黄婼璇, 宋彩娟. 2016—2021年郑州市肿瘤登记地区甲状腺癌发病和死亡趋势分析[J]. 预防医学, 2026, 38(3): 267-273.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed